Treatment with TPA
Introduction:
Stroke - also referred to as "brain attack" - is the third leading cause of
death in the United States after heart disease and cancer. It is the leading cause of
serious long term adult disability in the U.S.
In the past, the main treatment of stroke is prevention. After stroke the main
treatment is supportive care, minimize complications and prepare patient for stroke
rehabilitation.
ActivaseŽ (Tissue Plasminogen Activator), better known as TPA has been used for
treatment of acute heart attack for several years now. Its benefit in reducing the damage
from heart attack is clearly established.
It has now clearly shown that TPA can help to reduce the long term disability from a
stroke as well.
Stroke is slightly more complicated than a heart attack for several reasons: